These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 1705118)

  • 1. Potent anti-angiogenic action of AGM-1470: comparison to the fumagillin parent.
    Kusaka M; Sudo K; Fujita T; Marui S; Itoh F; Ingber D; Folkman J
    Biochem Biophys Res Commun; 1991 Feb; 174(3):1070-6. PubMed ID: 1705118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methionine aminopeptidase (type 2) is the common target for angiogenesis inhibitors AGM-1470 and ovalicin.
    Griffith EC; Su Z; Turk BE; Chen S; Chang YH; Wu Z; Biemann K; Liu JO
    Chem Biol; 1997 Jun; 4(6):461-71. PubMed ID: 9224570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The anti-angiogenic agent fumagillin covalently binds and inhibits the methionine aminopeptidase, MetAP-2.
    Sin N; Meng L; Wang MQ; Wen JJ; Bornmann WG; Crews CM
    Proc Natl Acad Sci U S A; 1997 Jun; 94(12):6099-103. PubMed ID: 9177176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth.
    Ingber D; Fujita T; Kishimoto S; Sudo K; Kanamaru T; Brem H; Folkman J
    Nature; 1990 Dec; 348(6301):555-7. PubMed ID: 1701033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of angiogenesis in vivo by interleukin 12.
    Voest EE; Kenyon BM; O'Reilly MS; Truitt G; D'Amato RJ; Folkman J
    J Natl Cancer Inst; 1995 Apr; 87(8):581-6. PubMed ID: 7538593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of angiogenesis inhibitor AGM-1470 on immune system status and tumor growth in vitro.
    Schoof DD; Obando JA; Cusack JC; Goedegebuure PS; Brem H; Eberlein TJ
    Int J Cancer; 1993 Oct; 55(4):630-5. PubMed ID: 7691763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemical modification of fumagillin. I. 6-O-acyl, 6-O-sulfonyl, 6-O-alkyl, and 6-O-(N-substituted-carbamoyl)fumagillols.
    Marui S; Itoh F; Kozai Y; Sudo K; Kishimoto S
    Chem Pharm Bull (Tokyo); 1992 Jan; 40(1):96-101. PubMed ID: 1374294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The potent angioinhibin AGM-1470 stimulates normal but not human tumoral lymphocytes.
    Antoine N; Daukandt M; Locigno R; Heinen E; Simar LJ; Castronovo V
    Tumori; 1996; 82(1):27-30. PubMed ID: 8623499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The rat Subcutaneous Air Sac model: a quantitative assay of antiangiogenesis in induced vessels.
    Lichtenberg J; Hjarnaa PJ; Kristjansen PE; Hansen D; Binderup L
    Pharmacol Toxicol; 1999 Jan; 84(1):34-40. PubMed ID: 9974188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory effects of fumagillin and its analogue TNP-470 on the function, morphology and angiogenesis of an oestrogen-induced prolactinoma in Fischer 344 rats.
    Stepień H; Grochal M; Zieliński KW; Mucha S; Kunert-Radek J; Kulig A; Stawowy A; Pisarek H
    J Endocrinol; 1996 Jul; 150(1):99-106. PubMed ID: 8708569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro inhibition of endothelial cell growth by the antiangiogenic drug AGM-1470 (TNP-470) and the anti-endoglin antibody TEC-11.
    Maier JA; Delia D; Thorpe PE; Gasparini G
    Anticancer Drugs; 1997 Mar; 8(3):238-44. PubMed ID: 9095328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of AGM-1470 and pentosan polysulphate on tumorigenicity and metastasis of FGF-transfected MCF-7 cells.
    McLeskey SW; Zhang L; Trock BJ; Kharbanda S; Liu Y; Gottardis MM; Lippman ME; Kern FG
    Br J Cancer; 1996 May; 73(9):1053-62. PubMed ID: 8624263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simulation of human B-lymphocyte proliferation by AGM-1470, a potent inhibitor of angiogenesis.
    Antoine N; Bours V; Heinen E; Simar LJ; Castronovo V
    J Natl Cancer Inst; 1995 Jan; 87(2):136-9. PubMed ID: 7535858
    [No Abstract]   [Full Text] [Related]  

  • 14. Investigation of novel fumagillin analogues as angiogenesis inhibitors.
    Pyun HJ; Fardis M; Tario J; Yang CY; Ruckman J; Henninger D; Jin H; Kim CU
    Bioorg Med Chem Lett; 2004 Jan; 14(1):91-4. PubMed ID: 14684305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TNP-470 (AGM-1470): mechanisms of action and early clinical development.
    Castronovo V; Belotti D
    Eur J Cancer; 1996 Dec; 32A(14):2520-7. PubMed ID: 9059342
    [No Abstract]   [Full Text] [Related]  

  • 16. Novel bicyclic oxazolone derivatives as anti-angiogenic agents.
    Perron-Sierra FM; Pierré A; Burbridge M; Guilbaud N
    Bioorg Med Chem Lett; 2002 Jun; 12(11):1463-6. PubMed ID: 12031320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytostatic inhibition of endothelial cell growth by the angiogenesis inhibitor TNP-470 (AGM-1470).
    Kusaka M; Sudo K; Matsutani E; Kozai Y; Marui S; Fujita T; Ingber D; Folkman J
    Br J Cancer; 1994 Feb; 69(2):212-6. PubMed ID: 8297716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of angiogenesis in the tumor growth of Syrian hamster pancreatic cancer cell line HPD-NR.
    Egawa S; Tsutsumi M; Konishi Y; Kobari M; Matsuno S; Nagasaki K; Futami H; Yamaguchi K
    Gastroenterology; 1995 May; 108(5):1526-33. PubMed ID: 7537236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of experimental antiangiogenic therapy.
    Brem H; Folkman J
    J Pediatr Surg; 1993 Mar; 28(3):445-50; discussion 450-1. PubMed ID: 7682259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of AGM-1470 in an improved intracranial 9L gliosarcoma rat model.
    Wilson JT; Penar PL
    Neurol Res; 1994 Apr; 16(2):121-4. PubMed ID: 7913996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.